Featured
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Catalent Completes RheinCell Therapeutics Acquisition
Plans to facilitate accelerated access to high-quality iPSC banks with integrated solutions from plasmid DNA manufacturing to clinical supply.08.04.21
-
Breaking News | Clinical Trials | CRO News | Industry News | Information Technology
Syneos Health, Aetion Partner on Regulatory-grade Data, Analytics Solutions
Combines Syneos’ data collection and research services with Aetion Evidence Platform to generate evidence through patient data curation and real-world data.08.04.21
-
Breaking News | Drug Delivery | Drug Development | Drug Discovery | Industry News
BioMed X, Janssen Begin Autoimmunity and Drug Delivery Research
New research groups, PTA and TMI, aim to combat chronic inflammatory diseases and develop oral delivery of macromolar therapeutics.08.04.21
-
Breaking News | Fill/Finish | Industry News
Pii to Offer West’s Daikyo Crystal Zenith Platform
To address the growing demand for high-quality and advanced containment systems, as well as small and medium-sized batches.08.04.21
-
Breaking News | cGMP Manufacture | Chemistry | Drug Development | Industry News
BMS Completes Sale of Couvet Site to WuXi STA
Acquisition significantly enhances WuXi STA's drug product capacity in Europe and enhances capabilities by adding capacity to support global customers.08.04.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Sanofi to Acquire Translate Bio for $3.2B
Upgrades drug formulation capabilities and accelerates development of licensed programs in vaccines and potential to explore other therapeutic areas.08.04.21
-
cGMP Manufacture | Formulation Development | Scale-up/Technology Transfer
Solving Solubility Challenges for a Novel Oncology Drug
Learn how Lubrizol Life Science Health solved bioavailability challenges and scaled a commercially viable formulation of a new cancer treatment.
-
Breaking News | Facilities | Industry News
WuXi STA Completes Acquisition of BMS Manufacturing Facility
State-of-the-art facility in Couvet, Switzerland enhances WuXi STA's drug product capacity in Europe.08.03.21
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News | Preclinical Outsourcing
Nanoform, Boehringer Ingelheim Sign Master Services Agreement
Will address bioavailability and solubility challenges in the pre-clinical early development stages.08.03.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments
DisperSol, Catalent Enter Manufacturing Collaboration
To establish KinetiSol technology manufacturing hub for DisperSol’s pipeline.08.03.21
-
Drug Development | Scale-up/Technology Transfer | Validation
Keys to Successful Tech Transfer for Topical Pharmaceuticals
This whitepaper illustrates the keys to choosing the right manufacturing partner and how to manage a topical drug tech transfer.
-
Breaking News | Financial Reports
Veklury Drives 2Q Growth for Gilead
Veklury (remdesivir) with sales of $829 million offsets loss of exclusivity of Truvada and Atripla in the U.S. with sales down 72% and 42%, respectively.07.30.21
-
Financial Reports
AbbVie's 2Q Revenue up 34%
New immunology assets Skyrizi and Rinvoq contribute more than $1 billion of combined sales in the quarter.07.30.21
-
Breaking News | Financial Reports
BMS 2Q Revenues up 16%
Top sellers Revlimid, Eliquis and Opdivo drive growth while established brands were down 64%.07.30.21
-
Action Trumps Fear
Move past the fear of failure during the job search by taking the right action steps.Online Exclusives Dave Jensen, Contributing Editor 07.30.21
- Akston Biosciences, Seppic Ink Commercial Supply Agreement
- Batavia to Develop Clinical Process for RocketVax’s COVID-19 Vaccine
- Swiss Government Turns to Swissfillon for COVID-19 Test Kit Production
- The Power and Promise of Decentralized Trials
- AbCellera to Build Antibody Manufacturing Facility in Canada
- Maintaining Critical Drug Supply During the Pandemic
- Ocugen, Jubilant Enter COVID-19 Vaccine Partnership
- BD Hits 2 Billion Injection Device Milestone for COVID-19 Vaccinations
- AGC Biologics Inks Supply Deal for COVID-19 Vaccine
- Waking from the “Coma of COVID-19”
- Catalent Completes RheinCell Therapeutics Acquisition
- Syneos Health, Aetion Partner on Regulatory-grade Data, Analytics Solutions
- BioMed X, Janssen Begin Autoimmunity and Drug Delivery Research
- Pii to Offer West’s Daikyo Crystal Zenith Platform
- BMS Completes Sale of Couvet Site to WuXi STA
- Sanofi to Acquire Translate Bio for $3.2B
- WuXi STA Completes Acquisition of BMS Manufacturing Facility
- Nanoform, Boehringer Ingelheim Sign Master Services Agreement
- DisperSol, Catalent Enter Manufacturing Collaboration
- Veklury Drives 2Q Growth for Gilead
Contract Service Directory
Search the Directories for A Company:
